# Ernexa Therapeutics Inc.: Form 8-K, filed Jul 13, 2023

- Company: [Ernexa Therapeutics Inc.](/companies/erna.md) (CIK 748592)
- Form: 8-K
- Filed: 2023-07-13
- Accepted by EDGAR: Jul 13, 2023, 06:02 ET
- Period: 2023-07-12
- Accession: 0001140361-23-034310
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/748592/000114036123034310/brhc20055786_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/748592/000114036123034310/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/748592/000114036123034310/brhc20055786_8k.htm

Filed Jul 13, 2023.
Source: SEC EDGAR, the filing index for accession 0001140361-23-034310. Last ingested by Listed: Oct 30, 2026, 14:05 ET. No prices; not investment advice.